Brain Age Gap Progression in Individuals at Risk for Neurodegeneration

Abstract

Neuroimaging is a widely used modality for characterizing neurodegeneration in various health conditions. Brain age gap has emerged as a promising biomarker for monitoring brain health from neuroimaging data using machine learning algorithms. Recent studies have leveraged coVariance neural networks (VNN)-driven pipelines based on the advancements in graph signal processing for relatively transparent construction of brain age gap from neuroimaging data. In this paper, we focus on a longitudinal study of VNN-based brain age gap in conjunction with Alzheimer's Progression Score (APS) in individuals that are at a higher risk of neurodegeneration due to family history of Alzheimer's disease. APS is a multimodal marker of disease progression. The longitudinal analysis of APS and VNN-derived brain age gap metrics revealed that a higher risk of disease progression at baseline predicted a larger rate of increase in brain age gap in follow-up visits. Thus, our findings revealed potential stratification in the brain age gap modulated by clinical/biological risks of AD in the at-risk population.

Abstract: arXiv descriptive metadata (CC0). Thank you to arXiv for use of its open access interoperability. This service was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, arXiv.